Skip to playerSkip to main content
  • 7 weeks ago
Screening for prostate cancer is more tailored than many individuals understand, with choices influenced by factors such as age, family medical history, ethnicity, overall health, and personal choices. The American Cancer Society advises that discussions regarding screening should begin at age 45 for Black males and those with a father or brother diagnosed before the age of 65, whereas men at average risk may start these conversations at 50. A PSA blood test can signal potential issues but does not confirm cancer; a biopsy is necessary for a definitive diagnosis. In certain cases of low-risk cancers, opting for active surveillance may be a suitable alternative to immediate treatment, striking a balance between cancer management and quality of life.
Disclosure:This video contains stock footage and content created or enhanced using Ai-assisted tools ai-generated
Transcript
00:00Prostate cancer screening does not automatically begin at age 50 for everyone.
00:05Screening decisions depend on age, family history, race, overall health, and personal preferences.
00:11The American Cancer Society recommends earlier discussions for men at higher risk.
00:16For many men, screening begins with a simple PSA blood test.
00:20But a high PSA does not necessarily mean prostate cancer.
00:24Enlarged prostate, infections, and other factors can also raise PSA levels.
00:28A normal PSA result does not completely rule out cancer either.
00:32If results remain concerning, doctors may recommend imaging or other tests.
00:37Only a prostate biopsy can confirm whether cancer is present.
00:41And finding prostate cancer does not always mean immediate treatment is needed.
00:45Some low-risk cancers can be safely monitored through active surveillance.
00:49Talking with a health care provider can help determine when screening is right for you.
00:53Disclosure. This video contains stock footage and content created or enhanced using AI-assisted tools AI generated.

Recommended